Form 4 for HCWB HCW Biologics Inc.
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001209191-24-003785 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | HCWB | Giles Lisa M. | Dir | A - Grant | $1.40 | +35.7K | 35.8K | +35,715% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | A | A | 35,715 | $1.40 | 35,815 | D | — | — |